WASHINGTON, May 2, 2025 /PRNewswire/ -- Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA) today announced it will release results for the first quarter 2025 on Wednesday, May 7, 2025, after the market ...
Good afternoon, and welcome to the Quarter One 2025 Vanda Pharmaceuticals Incorporated Earnings Conference Call. I am Franz, and I will be the operator assisting you today. All lines have been placed ...
Presentation Title: "Translating IGHMBP2 Variants with a CMT2S Patient-specific Organ-on-a-chip Model: Personalized Medicine ASO-based Therapeutic Rescue" Poster Presentation Session: P-12 Poster ...
To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min The ruling sets the stage for a ...
To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min The cost of the approved drug ...
Vanda ( (VNDA)) just unveiled an announcement. On February 18, 2026, Vanda’s board compensation committee approved 2025 cash bonuses for its named executive officers, including a bonus of $834,326 for ...
Thank you for standing by. My name is Jordan, and I'll be your conference operator today. At this time, I'd like to welcome Vanda Pharmaceuticals Inc. Earnings Conference Call. [Operator Instructions] ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results